I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 10 studies | 23% ± 7% | |
| oligodendrocyte | 10 studies | 28% ± 12% | |
| plasmacytoid dendritic cell | 8 studies | 22% ± 5% | |
| ciliated cell | 8 studies | 25% ± 11% | |
| endothelial cell | 7 studies | 29% ± 5% | |
| pericyte | 7 studies | 18% ± 3% | |
| astrocyte | 7 studies | 31% ± 10% | |
| epithelial cell | 6 studies | 38% ± 18% | |
| retinal rod cell | 6 studies | 23% ± 4% | |
| macrophage | 6 studies | 21% ± 5% | |
| oligodendrocyte precursor cell | 5 studies | 27% ± 9% | |
| natural killer cell | 5 studies | 16% ± 1% | |
| plasma cell | 4 studies | 28% ± 13% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 18% ± 3% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 4 studies | 17% ± 3% | |
| microglial cell | 4 studies | 20% ± 4% | |
| basal cell | 4 studies | 32% ± 7% | |
| GABAergic neuron | 4 studies | 32% ± 10% | |
| connective tissue cell | 4 studies | 20% ± 5% | |
| goblet cell | 4 studies | 28% ± 12% | |
| plasmablast | 3 studies | 47% ± 16% | |
| CD4-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
| non-classical monocyte | 3 studies | 19% ± 5% | |
| naive B cell | 3 studies | 16% ± 1% | |
| B cell | 3 studies | 16% ± 1% | |
| club cell | 3 studies | 19% ± 1% | |
| retina horizontal cell | 3 studies | 19% ± 2% | |
| retinal cone cell | 3 studies | 30% ± 3% | |
| rod bipolar cell | 3 studies | 27% ± 4% | |
| abnormal cell | 3 studies | 20% ± 4% | |
| type I pneumocyte | 3 studies | 17% ± 1% | |
| glutamatergic neuron | 3 studies | 44% ± 5% | |
| dendritic cell | 3 studies | 30% ± 11% | |
| smooth muscle cell | 3 studies | 17% ± 2% | |
| myofibroblast cell | 3 studies | 20% ± 3% | |
| adipocyte | 3 studies | 23% ± 6% | |
| regulatory T cell | 3 studies | 16% ± 1% |
